We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compensatory Cognitive Training in Clinical High Risk Latino Youth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02245607
Recruitment Status : Unknown
Verified February 2021 by Kristin Cadenhead, M.D., University of California, San Diego.
Recruitment status was:  Active, not recruiting
First Posted : September 19, 2014
Last Update Posted : February 8, 2021
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Kristin Cadenhead, M.D., University of California, San Diego

Tracking Information
First Submitted Date  ICMJE September 16, 2014
First Posted Date  ICMJE September 19, 2014
Last Update Posted Date February 8, 2021
Study Start Date  ICMJE October 2014
Actual Primary Completion Date June 30, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: February 3, 2021)
Neurocognition (Global Cognitive Index z score) [ Time Frame: 3 and 6 months post-baseline ]
The CGI is derived based on Z scores across multiple neurocognitive domains and is a representation of global cognition
Original Primary Outcome Measures  ICMJE
 (submitted: September 17, 2014)
Neurocognition (Global Cognitive Index z score) [ Time Frame: 3 and 6 months post-baseline ]
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: February 3, 2021)
Functional capacity (UPSA/UPSA-A) [ Time Frame: 3 and 6 month post-baseline ]
The UPSA total Functional Capacity score is the total of all subscale scores on the UPSA (Finances, Communication, Transportation, Household)
Original Secondary Outcome Measures  ICMJE
 (submitted: September 17, 2014)
Functional capacity (UPSA/UPSA-A) [ Time Frame: 3 and 6 month post-baseline ]
Current Other Pre-specified Outcome Measures
 (submitted: February 3, 2021)
  • Self-reported functioning (SLoF) [ Time Frame: 3 and 6 month post-baseline ]
    The specific level of functioning (SLOF) assessment scale measures observable behavioral functioning and daily living skills.
  • Clinical symptom severity (SOPS total) [ Time Frame: 3 and 6 month post-baseline ]
    The Scale of Prodromal Symptoms (SOPS) measures positive, negative, disorganized and general symptoms seen in psychotic illness. The total score is used for outcome.
Original Other Pre-specified Outcome Measures
 (submitted: September 17, 2014)
  • Self-reported functioning (SLoF) [ Time Frame: 3 and 6 month post-baseline ]
  • Clinical symptom severity (SOPS total) [ Time Frame: 3 and 6 month post-baseline ]
 
Descriptive Information
Brief Title  ICMJE Compensatory Cognitive Training in Clinical High Risk Latino Youth
Official Title  ICMJE Compensatory Cognitive Training in Clinical High Risk Latino Youth
Brief Summary

This is a randomized study to compare Compensatory Cognitive Training (CCT) versus Recreational Therapy (RT) in Latino clinical high risk individuals in the US and Mexico.

Study hypotheses: Compared to those who receive RT, study participants receiving CCT will show significant improvement in neurocognition, functional capacity, self-rated functioning and clinical measures.

Detailed Description

This is a 12 week randomized study to compare Compensatory Cognitive Training (CCT) versus Recreational Therapy (RT) in Latino clinical high risk individuals in the US and Mexico.

Study participants will be measured 3 times, at baseline, 12 and 24 weeks on all outcome measures. Study hypothesis: Study participants receiving CCT will show significant improvement at 12 and 24 weeks compared to baseline in 1) Neurocognition using the Global Cognitive Index z score derived from the MATRICS neurocognitive domain scores, 2) Functional Capacity as assessed by the UCSD Performance-based Skills Assessment (UPSA/UPSA-Adolescent), 3) Self-Rated Functioning as measured by the Specific Level of Functioning Scale (SLoF) and 4) Clinical symptom ratings as measured by the Scale of Prodromal Symptoms (SOPS) total score when compared to subjects receiving RT training across study time.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE
  • Clinical High Risk
  • Psychosis
  • Prodromal
  • Schizophrenia
Intervention  ICMJE
  • Behavioral: Compensatory Cognitive Training
  • Behavioral: Recreational Therapy
Study Arms  ICMJE
  • Experimental: Compensatory Cognitive Training
    Compensatory Cognitive Training
    Intervention: Behavioral: Compensatory Cognitive Training
  • Active Comparator: Recreational Therapy
    Recreational Therapy
    Intervention: Behavioral: Recreational Therapy
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Unknown status
Estimated Enrollment  ICMJE
 (submitted: September 17, 2014)
120
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE February 1, 2021
Actual Primary Completion Date June 30, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Meet Clinical High Risk criteria
  • Be of Latino descent
  • Speak Spanish as their preferred language

Exclusion Criteria:

  • Concomitant medical or neurological illness
  • Brain injury with loss of consciousness > 30 minutes
  • Current substance abuse (excluding nicotine)
  • IQ < 80
  • High suicidal risk
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 12 Years to 30 Years   (Child, Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Mexico,   United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02245607
Other Study ID Numbers  ICMJE MH105247
5R34MH105247-03 ( U.S. NIH Grant/Contract )
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Kristin Cadenhead, M.D., University of California, San Diego
Original Responsible Party Same as current
Current Study Sponsor  ICMJE University of California, San Diego
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE National Institute of Mental Health (NIMH)
Investigators  ICMJE
Principal Investigator: Kristin Cadenhead, MD University of California, San Diego
PRS Account University of California, San Diego
Verification Date February 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP